Highlighting antimicrobial resistance challenges in Ukraine on the UK Parliament

Photo-1_150 pdi
On 3 November 2026, Elena Moshynets, coordinator of the SURE-AMR project, provided oral evidence to the UK Parliament’s International Development Committee during a session dedicated to the humanitarian situation in Ukraine. She addressed the growing challenges of antimicrobial resistance (AMR) in the country, alongside Dr Luke Moore, an infectious diseases specialist at Chelsea and Westminster Hospital.

 

The session examined the impact of Russia’s ongoing invasion on Ukraine’s healthcare system, bringing together experts to discuss the challenges facing the country and opportunities for international support.

Moshynets highlighted the difficulties Ukrainian hospitals face in preventing and treating infections caused by multidrug-resistant bacteria. These include shortages of healthcare professionals, limited access to essential antibiotics, insufficient funding and challenges in implementing infection prevention and control measures.

She also drew attention to the high prevalence of resistant bacteria in war-related wound infections and the need for evidence-based treatment guidelines adapted to Ukraine’s healthcare resources. Dr Moore, infectious diseases specialist at Chelsea and Westminster Hospital emphasised that antimicrobial resistance extends beyond Ukraine, representing a global public health threat that requires international cooperation.

Strengthening research capacities through international cooperation

During the session, Dr Moshynets also introduced the SURE-AMR project, which aims to strengthen Ukraine’s research capacities in antimicrobial resistance surveillance and prevention through international cooperation and a One Health approach.

Her participation provided an opportunity to bring scientific expertise and first-hand experience from Ukraine into international policy discussions, highlighting the importance of research collaboration, effective surveillance and access to appropriate treatments in tackling antimicrobial resistance.

 

 

Related